Report of the Post Kala-Azar Dermal Leishmaniasis (PKDL) consortium meeting, New Delhi, India, 27–29 June 2012
Open Access
- 2 July 2013
- journal article
- Published by Springer Science and Business Media LLC in Parasites & Vectors
- Vol. 6 (1), 196-21
- https://doi.org/10.1186/1756-3305-6-196
Abstract
Post kala-azar dermal leishmaniasis (PKDL) is a neglected complication of visceral leishmaniasis (VL)―a deadly, infectious disease that claims approximately 20,000 to 40,000 lives every year. PKDL is thought to be a reservoir for transmission of VL, thus, adequate control of PKDL plays a key role in the ongoing effort to eliminate VL. Over the past few years, several expert meetings have recommended that a greater focus on PKDL was needed, especially in South Asia. This report summarizes the Post Kala-Azar Dermal Leishmaniasis Consortium Meeting held in New Delhi, India, 27–29 June 2012. The PKDL Consortium is committed to promote and facilitate activities that lead to better understanding of all aspects of PKDL that are needed for improved clinical management and to achieve control of PKDL and VL. Fifty clinicians, scientists, policy makers, and advocates came together to discuss issues relating to PKDL epidemiology, diagnosis, pathogenesis, clinical presentation, treatment, and control. Colleagues who were unable to attend participated during drafting of the consortium meeting report.Keywords
This publication has 42 references indexed in Scilit:
- Leishmaniasis Worldwide and Global Estimates of Its IncidencePLOS ONE, 2012
- Post-Kala-azar Dermal Leishmaniasis in Nepal: A Retrospective Cohort Study (2000–2010)PLoS Neglected Tropical Diseases, 2011
- Miltefosine as an effective choice in the treatment of post-kala-azar dermal leishmaniasisBritish Journal of Dermatology, 2011
- Enhanced Case Detection and Improved Diagnosis of PKDL in a Kala-azar-Endemic Area of BangladeshPLoS Neglected Tropical Diseases, 2010
- Increasing Incidence of Post–Kala‐Azar Dermal Leishmaniasis in a Population‐Based Study in BangladeshClinical Infectious Diseases, 2010
- Visceral Leishmaniasis Elimination Programme in India, Bangladesh, and Nepal: Reshaping the Case Finding/Case Management StrategyPLoS Neglected Tropical Diseases, 2009
- Oral miltefosine in the treatment of post-kala-azar dermal leishmaniasisClinical and Experimental Dermatology, 2007
- Successful miltefosine treatment of post-kala-azar dermal leishmaniasis occurring during antiretroviral therapyPathogens and Global Health, 2006
- Evaluation of Enzyme-Linked Immunosorbent Assay for Diagnosis of Post-Kala-Azar Dermal Leishmaniasis with Crude or Recombinant k39 AntigenClinical and Vaccine Immunology, 2002
- Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatmentTransactions of the Royal Society of Tropical Medicine and Hygiene, 1992